Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Colinz Laboratories Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Colinz Laboratories Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Colinz Laborator - Integrated Filing (Financial)

    4 Mar 2025, 11:44AM Pursuant to SEBI Cercular No SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated 31-12-2024 read with BSE circular 20250102-4, we are submitting herewith the I
  • Colinz Laborator Q3 net profit down 54.55% at Rs 0.05 cr

    31 Jan 2025, 6:40PM The company reported standalone net profit of Rs 0.05 crore for the quarter ended December 31, 2024 as compared to Rs 0.11 crore in the same period la
  • Colinz Laborator - Outcome Of The Board Meeting Under Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Require

    31 Jan 2025, 5:53PM As required under Regulation 30 of SEBI, we are pleased to submit our Financial Unaudited Results for the Quarter and None Months Ended on 31-12-2024.
  • Colinz Laborator - Board Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30 And 33 Of SEBI (Listing Obligat

    31 Jan 2025, 5:49PM We would like to inform you that, the Board of Directors of the Company at their meeting held today i.e. 31st January, 2025 has, inter alia considered
  • Colinz Laborator - Board Meeting Intimation for Notice Of Date Of Board Meeting Pursuant To Regulation 29(2) Of SEBI (LODR)

    13 Jan 2025, 7:02PM COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 ,inter alia, to consider
  • Colinz Laborator - Pursuant To Regulation 13 (3) Of The SEBI (Listing Obligations And Disclosure Requirement) Regulations, 20

    8 Jan 2025, 4:15PM Pursuant to Regulation 13(3) of the SEBI(LODR), Regulation 2015, the Statement of Investor Complaints for the Quarter Ended on 31-12-2024.\r\n\r\nXBRL
  • Colinz Laborator - Intimation To Exchange Pursuant To Regulation 13(3) Of The SEBI (Listing Obligations And Disclosure Requir

    8 Jan 2025, 4:10PM Pursuant to Regulation 13(3) of SEBI (LODR), Regulation,2015 the Statement of Investor Grievance for the Quarter ended on 31-12-2024.\r\n\r\nKindly th
  • Colinz Laborator - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Jan 2025, 4:03PM Please find the attached Certificate received form our RTA M/s. Bigshare Services Pvt Ltd in Compliance under Regulation 74(5) of SEBI (Depositories a
  • Colinz Laborator - Declaration With Respect To Non-Applicability Of Related Party Transactions Pursuant To Regulations 23(9)

    2 Jan 2025, 3:41PM As required under 15(2). of SEBI(LODR) Regulation ,2015, and other applicable provision Company claiming exemption under Regulation 15(2) a of the SEB
  • Colinz Laborator - Declaration Of Non-Applicability Of Reg. 32 Of The SEBI (LODR) Regulations, 2015 (Statement Of Deviation O

    2 Jan 2025, 3:34PM This is to inform your that as per Regulation 32 of SEBI(LODR), Regulation, 2015 and (Statement of Deviation or variation of proceeds of public issues

Key fundamentals

Evaluate the intrinsic value of Colinz Laboratories Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 9.5187 8.4126 8.1719 8.2838 7.2182
Liabilities 9.5187 8.4126 8.1719 8.2838 7.2182
Equity 2.5191 2.5191 3.545 3.545 3.5441
Gross Profit 0.5428 0.6089 0.5861 0.1406 0.3027
Net Profit 0.4867 0.4574 0.3393 0.2075 0.1304
Cash From Operating Activities 1.0347 0.4029 0.4671 2.158 0.5805
NPM(%) 6.92 6.39 4.86 3.37 1.71
Revenue 7.0296 7.1549 6.9742 6.1589 7.6032
Expenses 6.4868 6.546 6.3881 6.0183 7.3005
ROE(%) 5.43 5.11 3.79 2.31 1.45

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Colinz Laboratories Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 809.25 -0.64 11.41 34.28 1321.50 1.42
Lotus Eye Hospital and Institute Ltd 58.19 1.50 237.75 124.90 14.01 0.88
Bharat Immunological and Biologicals Corporation Ltd 21.32 -1.30 0.00 259.34 -39.50 0.00
Astec Lifesciences Ltd 654.90 -5.39 0.00 117.77 -239.30 0.00

Company Info

Colinz Laboratories Ltd., was incorporated under the Companies Act,1956, in the year 1986, as a private limited company and obtained certificate of registration No. 41128 of 1986 on 16th October 1986. The Company was later converted into a public limited company and obtained Certificate of Change of name under the Companies Act, 1956 on 5th January 1995, from the Registrar of Companies, Maharashtra. Though the company was incorporated in the year 1986, the activities of production and marketing was started only in the year 1990. The company is listed in Bombay Stock Exchange. The Company is coming under S.M.E. category. The company is manufacturing and marketing various allopathic and Ayurvedic pharmaceutical formulations in the dosage forms of tablets, capsules, liquid orals, ointments etc. The company promotes its products in the states of Maharashtra, Karnataka, Andhra Pradesh, Gujarat, Rajasthan, MP, CG and also in West Bengal through its own marketing staff.

Colinz Laboratories Ltd., was incorporated under the Companies Act,1956, in the year 1986, as a private limited company and obtained certificate of registration No. 41128 of 1986 on 16th October 1986. The Company was later converted into a public limited company and obtained Certificate of Change of name under the Companies Act, 1956 on 5th January 1995, from the Registrar of Companies, Maharashtra. Though the company was incorporated in the year 1986, the activities of production and marketing was started only in the year 1990. The company is listed in Bombay Stock Exchange. The Company is coming under S.M.E. category. The company is manufacturing and marketing various allopathic and Ayurvedic pharmaceutical formulations in the dosage forms of tablets, capsules, liquid orals, ointments etc. The company promotes its products in the states of Maharashtra, Karnataka, Andhra Pradesh, Gujarat, Rajasthan, MP, CG and also in West Bengal through its own marketing staff.

Read More

Parent Organisation

Colinz Laboratories Ltd.

Founded

06/10/1986

Managing Director

NSE Symbol

FAQ

The current price of Colinz Laboratories Ltd is

The 52-week high for Colinz Laboratories Ltd is

The market capitalization of Colinz Laboratories Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Colinz Laboratories Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Colinz Laboratories Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Colinz Laboratories Ltd shares.

The CEO of Colinz Laboratories Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT